Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy - PLUS

CompletedOBSERVATIONAL
Enrollment

923

Participants

Timeline

Start Date

June 11, 2019

Primary Completion Date

October 27, 2024

Study Completion Date

October 27, 2024

Conditions
Carcinoma, Non-Small-Cell Lung
Trial Locations (10)

Unknown

Research Site, Busan

Research Site, Chungcheongbuk-do

Research Site, Daegu

Research Site, Daejeon

Research Site, Gangwon State

Research Site, Gyeonggi-do

Research Site, Incheon

Research Site, Jeollabuk-do

Research Site, Jeollanam-do

Research Site, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY